Tech Company Financing Transactions
Respira Therapeutics Funding Round
Private investors participated in a $9.1 million funding round for Respira Therapeutics. The round closed on 4/27/2017.
Transaction Overview
Company Name
Announced On
4/27/2017
Transaction Type
Venture Equity
Amount
$9,105,810
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 3 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5901 Indian School Rd. NE 107
Albuquerque, NM 87110
USA
Albuquerque, NM 87110
USA
Phone
Undisclosed
Website
Email Address
Overview
Respira is a product development-stage company focused on pulmonary delivery of therapeutics for respiratory diseases with unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Curtis
Chief Financial Officer
Christine Hanni
Vice President
Andrew Clark
Browse more venture capital transactions:
Prev: 4/27/2017: Zero Motorcycles venture capital transaction
Next: 4/27/2017: OverOps venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs